-
Baekje Shenzhou Tirelizumab has been approved for marketing by the FDA
On March 15th, Baekje announced that the US Food and Drug Administration (FDA) has approved tirizumab as a monotherapy for adult patients with unresectable or metastatic esophageal squamous cell carc ... -
BeiGene: Tirelizumab Approved for Market by FDA
On March 15th, Securities Daily News reported that BeiGene announced that the company has recently learned that the US Food and Drug Administration (FDA) has approved the company's core product, Tera ...